文献速递小儿神经外科与脑积水功能神经外科

立体定向内分流置入术治疗先天性颅内囊肿

Stereotactic Internal Shunt Placement in Congenital Intracranial Cysts.
PubMed 文献 · World Neurosurg · 2018-12-18

该研究基于2009至2017年前瞻性数据库,连续纳入38例症状性未治疗颅内囊肿患者,接受立体定向内分流置入术,要求至少随访6个月。2年无囊肿复发生存率为97%,临床症状改善率91%,囊肿缩小率97%,总并发症率11%,长期并发症率2.6%;总并发症率未见相关危险因素,临床症状改善率及总并发症、长期并发症率与替代治疗相比更优(P < 0.01)。作者结论为该技术安全,可用于脑内任何部位的囊性病变。

要点

  • 38例症状性颅内囊肿行立体定向内分流置入术,2年无复发生存率97%。
  • 临床症状改善率91%,囊肿缩小率97%,总并发症率11%,长期并发症率2.6%。
  • 临床症状改善率及并发症率与替代治疗相比更优(P < 0.01)。

核心结论

  • 所描述的立体定向内分流置入技术安全,可成功应用于脑内任何部位的囊性病变治疗。

研究设计与样本

  • 前瞻性数据库连续纳入2009至2017年症状性未治疗颅内囊肿行内分流术患者38例,要求至少随访6个月。

主要发现

  • 囊肿位置包括小脑(n = 2)、脑干(n = 5)、松果体区(n = 4)。
  • 囊肿相关脑积水(n = 6)治疗后消退。
  • 2年无囊肿复发生存率为97%。
  • 临床症状改善率91%,囊肿缩小率97%,总并发症率11%,长期并发症率2.6%。
  • 未发现与总并发症率相关的危险因素;临床症状改善率及总并发症、长期并发症率与替代治疗相应估计相比更优(P < 0.01)。

临床怎么用

  • 作者认为该立体定向内分流置入技术安全,可成功应用于脑内任何部位的囊性病变治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Treatment of symptomatic intracranial cysts remains a controversial issue. We present a risk/benefit profile of a minimally invasive, not yet described, stereotactic internal shunt implantation technique. The provided data might serve as a reference against which other treatment modalities could be compared. METHODS: From our prospective database, we identified a consecutive series of patients with symptomatic, untreated cysts who had undergone internal shunting from 2009 to 2017. We estimated the rates of clinical symptom improvement (RCSI), cyst reduction, total complications, and long-term complications. A minimal follow-up of 6 months was required. The prognostic factors were obtained from logistic regression models. Cyst recurrence-free survival was calculated using the Kaplan-Meier method. The outcomes data were compared with those from reported alternative treatment strategies using χ2 statistics. RESULTS: We included 38 patients. The cyst locations differed greatly and included the cerebellum (n = 2), brainstem (n = 5), and pineal area (n = 4). Cyst-associated hydrocephalus (n = 6) resolved after treatment. The 2-year cyst recurrence-free survival rate was 97%. The RCSI and rate of cyst reduction, total complications, and long-term complications was 91%, 97%, 11%, and 2.6%, respectively. We did not find any risk factors associated with the rate of total complications. The RCSI and rate of total and long-term complications compared favorably (P < 0.01) with the corresponding estimates of alternative treatments (P < 0.01). CONCLUSIONS: The described stereotactic internal shunt implantation technique is safe and can be successfully applied for treatment of cystic formations in any location in the brain.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lenski M, Biczok A, Tonn JC, et al. Stereotactic Internal Shunt Placement in Congenital Intracranial Cysts. World Neurosurg. 2018. PMID: 30576829. doi:10.1016/j.wneu.2018.11.250

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。